Positive Late-Breaking Data for Incytes First-in-Class mutCALR-targeted therapy INCA033989 in Essential Thrombocythemia Presented at EHA2025
Data demonstrates the potential for INCA033989 to modify disease by directly inhibiting…
KBRA Comments on Amendment to Sunnovas Loan Guarantee Agreement with DOE
NEW YORK--(BUSINESS WIRE)--#creditratingagency--In an 8-K filing with the Securities and Exchange Commission…